Extrait

Anti-Xa levels will be measured 4 hours (± 1 hour) after subcutaneous injection of nadroparin on day 1 or day 2, day 3 and day 5 of treatment (if applicable day 10 of treatment). Primary outcome is the degree of accumulation, defined as the percentage of increase of anti-Xa level on day 5 compared to day 1. This primary outcome will be assessed for various levels of renal function

Critère d'inclusion

• Venous Thromboembolism

Liens

• ictrp
• euctr